Predictors of response and survival for neoadjuvant treated patients with esophageal adenocarcinoma
Authors:
- 1 October 2008
- journal article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 21 (7) , 601-606
Abstract
Summary. Mainly patients with advanced esophageal adenocarcinoma who respond to neoadjuvant chemotherapy show a significant survival benefit after resection. TKeywords
This publication has 24 references indexed in Scilit:
- The Role of Integrated Computed Tomography Positron-Emission Tomography in Esophageal Cancer: Staging and Assessment of Therapeutic ResponseSeminars in Radiation Oncology, 2007
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Real time quantitative PCR.Genome Research, 1996
- The Significance of c-erb B-2 and p53 Immunoreactivity in Patients with Adenocarcinoma of the EsophagusAnnals of Surgery, 1995
- Carcinoma of the esophagus: Prognostic significance of histologic typeThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Expression of π-glutathione S-transferase gene (GSTP1) in gastric cancer: Lack of correlation with resistance against cis-diamminedichloroplatinum (II)European Journal of Cancer, 1994
- Molecular characterization of the human excision repair gene : cDNA cloning and amino acid homology with the yeast DNA repair geneCell, 1986
- Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylateBiochemistry, 1974
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957